0001623919-16-000058.txt : 20160331 0001623919-16-000058.hdr.sgml : 20160331 20160331161828 ACCESSION NUMBER: 0001623919-16-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160329 FILED AS OF DATE: 20160331 DATE AS OF CHANGE: 20160331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EndoChoice Holdings, Inc. CENTRAL INDEX KEY: 0001623919 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 900886803 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11810 WILLS ROAD CITY: ALPHARETTA STATE: GA ZIP: 30009 BUSINESS PHONE: 888-682-3636 MAIL ADDRESS: STREET 1: 11810 WILLS ROAD CITY: ALPHARETTA STATE: GA ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: ECPM Holdings, LLC DATE OF NAME CHANGE: 20141031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilreath Mark CENTRAL INDEX KEY: 0001643821 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37414 FILM NUMBER: 161543495 MAIL ADDRESS: STREET 1: 11810 WILLS ROAD CITY: ALPHARETTA STATE: GA ZIP: 30009 4 1 wf-form4_145945549752071.xml FORM 4 X0306 4 2016-03-29 0 0001623919 EndoChoice Holdings, Inc. GI 0001643821 Gilreath Mark C/O ENDOCHOICE HOLDINGS, INC. 11405 OLD ROSWELL ROAD ALPHARETTA GA 30009 1 1 0 0 Chief Executive Officer Common stock, par value $0.001 per share 74755 I By Mark Gregory Gilreath Irrevocable Trust Common stock, par value $0.001 per share 12243 I By Entrust Georgia, LLC for the benefit of Mark G. Gilreath Common stock, par value $0.001 per share 3200 I By Spouse Common stock, par value $0.001 per share 1818 I By Daughter Common stock, par value $0.001 per share 2016-03-29 4 A 0 32957 0 A 786207 D Employee Stock Option (right to buy) 5.31 2016-03-29 4 A 0 71645 0 A 2026-03-29 Common stock, par value $0.001 per share 71645.0 71645 D These shares represent an award of restricted stock units that will be settled in common stock upon vesting. The restricted stock units will vest over a four-year period with the first 25% vesting on March 29, 2017 and the remainder vesting ratably on the 29th of each month thereafter for a period of 36 months. The total direct shares shown include 280,796 time-vesting restricted stock and/or unit award shares. This stock option will vest over a four-year period with the first 25% vesting on March 29, 2017 and the remainder vesting ratably on the 29th of each month thereafter for a period of 36 months. /s/ James B. Young, Jr., under Power of Attorney for Mark G. Gilreath 2016-03-31